Fecal Occult Blood Test: Screening for Hidden Blood in Stool
📊 Quick facts about fecal occult blood test
💡 The most important things you need to know
- FIT is the preferred test: The fecal immunochemical test (FIT) is more accurate than older guaiac tests and requires no dietary restrictions
- A positive test does NOT mean cancer: About 95% of people with positive results do NOT have colorectal cancer - hemorrhoids and polyps are more common causes
- Follow-up colonoscopy is essential: If your test is positive, a colonoscopy is needed to find the source of bleeding and rule out cancer
- Annual testing saves lives: Regular screening reduces colorectal cancer mortality by approximately 22%
- Easy to do at home: The test involves collecting a small stool sample at home and returning it for analysis
- Start screening at 45: Current guidelines recommend colorectal cancer screening beginning at age 45 for average-risk adults
What Is a Fecal Occult Blood Test?
A fecal occult blood test (FOBT) is a non-invasive screening test that detects hidden (occult) blood in your stool. This blood is invisible to the naked eye but can be an early warning sign of colorectal cancer, precancerous polyps, or other gastrointestinal conditions. The test is a cornerstone of colorectal cancer screening programs worldwide.
The term "occult" comes from the Latin word for "hidden." When cancer or large polyps develop in the colon or rectum, they can bleed small amounts of blood that mix with stool. This bleeding often occurs intermittently and in quantities too small to notice, but a fecal occult blood test can detect even tiny traces of blood that would otherwise go unnoticed.
Colorectal cancer is one of the most common cancers worldwide and a leading cause of cancer-related deaths. However, it is also one of the most preventable cancers when detected early through screening. The fecal occult blood test plays a crucial role in this prevention strategy because it can identify potential problems years before symptoms develop, when treatment is most effective and often curative.
The biology behind this test is straightforward: cancerous and precancerous growths in the colon have fragile blood vessels that can rupture during normal bowel movements. The resulting microscopic bleeding releases hemoglobin (the oxygen-carrying protein in red blood cells) into the stool. Modern fecal occult blood tests are designed to detect this hemoglobin, even in concentrations as low as a few micrograms per gram of stool.
Types of Fecal Occult Blood Tests
There are two main types of fecal occult blood tests available, each using different technology to detect blood in stool samples. Understanding the differences between these tests can help you make informed decisions about your screening options.
The Fecal Immunochemical Test (FIT), also known as iFOBT (immunochemical fecal occult blood test), is the modern standard for stool-based colorectal cancer screening. This test uses antibodies that specifically recognize human hemoglobin, the protein that carries oxygen in red blood cells. Because FIT only reacts to human blood, it does not produce false positive results from dietary sources like red meat or certain vegetables.
The guaiac-based Fecal Occult Blood Test (gFOBT) is an older method that uses a chemical reaction to detect the peroxidase activity of hemoglobin. When blood is present in the stool sample, it causes a color change in the guaiac paper. While effective, this test can react to blood from any source, including food, which means dietary restrictions are necessary before and during testing.
| Feature | FIT (Immunochemical) | gFOBT (Guaiac) |
|---|---|---|
| Dietary restrictions | None required | Avoid red meat, vitamin C, NSAIDs |
| Samples needed | Usually 1 sample | Usually 3 samples over 3 days |
| Specificity | Higher (detects only human blood) | Lower (can detect animal blood) |
| Sensitivity for cancer | 74-92% | 50-75% |
Why Is the Fecal Occult Blood Test Done?
The fecal occult blood test is primarily used as a screening tool for colorectal cancer in adults aged 45-75 years. It can detect early-stage cancers and precancerous polyps before symptoms develop, when treatment is most effective. The test may also be used to investigate unexplained anemia or suspected gastrointestinal bleeding.
The primary purpose of fecal occult blood testing is colorectal cancer screening. Colorectal cancer typically develops slowly over many years, often beginning as non-cancerous growths called polyps on the inner lining of the colon or rectum. Not all polyps become cancerous, but certain types (adenomatous polyps) can transform into cancer if left untreated. By detecting blood that may indicate the presence of polyps or early-stage cancer, the fecal occult blood test enables intervention before the disease progresses.
The evidence supporting colorectal cancer screening is compelling. Multiple randomized controlled trials have demonstrated that regular screening with fecal occult blood tests reduces colorectal cancer mortality by approximately 15-33%, with most studies showing around a 22% reduction. This mortality benefit comes from detecting cancers at earlier, more treatable stages and from removing precancerous polyps during follow-up colonoscopies.
Beyond routine screening, healthcare providers may recommend fecal occult blood testing in several clinical scenarios. If you have unexplained iron-deficiency anemia, the test can help determine whether gastrointestinal blood loss might be contributing. Similarly, if you report symptoms like changes in bowel habits, unexplained weight loss, or abdominal discomfort, your doctor might order this test as part of the diagnostic workup.
Who Should Get Tested?
Current international guidelines recommend that all adults at average risk for colorectal cancer begin screening at age 45 and continue through age 75. The U.S. Preventive Services Task Force (USPSTF), American Cancer Society, and American College of Gastroenterology all support this recommendation based on extensive evidence showing the benefits of early detection.
For adults aged 76-85, the decision to screen should be individualized based on overall health, life expectancy, and personal preferences. Screening is generally not recommended for adults over 85 years old, as the potential benefits decrease while risks of follow-up procedures increase with age.
Some individuals have higher-than-average risk for colorectal cancer and may need to begin screening earlier or use different screening methods. These risk factors include a personal or family history of colorectal cancer or polyps, inflammatory bowel disease (Crohn's disease or ulcerative colitis), certain genetic syndromes like Lynch syndrome or familial adenomatous polyposis, or a history of abdominal or pelvic radiation therapy.
If you choose fecal occult blood testing (FIT or gFOBT) as your primary screening method, you should repeat the test annually. Missing years of screening reduces the test's effectiveness in preventing cancer deaths. Alternative screening options include colonoscopy every 10 years, flexible sigmoidoscopy every 5 years, or CT colonography every 5 years.
How Do You Prepare for the Test?
For the FIT test, no special preparation or dietary restrictions are needed. For the older gFOBT, you may need to avoid red meat, certain fruits and vegetables, vitamin C supplements, and NSAIDs for 3 days before and during sample collection. Always follow the specific instructions provided with your test kit.
One of the significant advantages of the fecal immunochemical test (FIT) is its simplicity and convenience. Unlike older testing methods, FIT requires no dietary modifications before or during sample collection. You can eat your normal diet, take your regular medications, and collect the sample at your convenience. This ease of use has contributed to higher participation rates in colorectal cancer screening programs.
If you are using a guaiac-based fecal occult blood test (gFOBT), preparation is more involved. The chemical reaction used in gFOBT can be triggered by substances other than human blood, leading to false positive results. To minimize this risk, you should follow specific dietary and medication guidelines starting three days before you collect your first sample and continuing until you complete the test.
Preparation for gFOBT
When preparing for a guaiac-based test, dietary modifications are essential for accurate results. You should avoid red meat (beef, lamb, pork) and processed meat products, as the hemoglobin from animal blood can cause false positive results. Raw fruits and vegetables containing peroxidase enzymes, such as turnips, horseradish, broccoli, cauliflower, and cantaloupe, should also be limited.
Certain medications and supplements can interfere with gFOBT results. Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin can cause gastrointestinal bleeding, potentially leading to true positive results unrelated to cancer. Vitamin C supplements in doses greater than 250mg per day can cause false negative results by interfering with the chemical reaction. Iron supplements do not affect the test but can darken stool color.
The timing of your test is also important. Women should avoid collecting samples during menstruation or within three days afterward, as menstrual blood can contaminate the sample. Similarly, if you have hemorrhoids that are actively bleeding or if you have recently had a rectal examination, digital prostate exam, or hemorrhoid treatment, you should wait until any bleeding has stopped before collecting samples.
Sample Collection Process
Collecting a stool sample may feel awkward at first, but the process is straightforward and can be done in the privacy of your own bathroom. Most test kits include detailed instructions, but understanding the general process can help you feel more prepared and ensure accurate results.
Begin by reading all instructions included with your test kit before you need to collect a sample. Different brands and test types may have slightly different procedures, so it's important to follow the specific directions provided. Make sure you have all the necessary supplies ready, including the collection device, test cards or tubes, and any protective equipment like gloves.
When you're ready to collect, most tests require you to catch the stool before it touches toilet water, as water can dilute the sample. Some kits provide a collection container that fits under the toilet seat, while others instruct you to place plastic wrap or a clean container in the toilet bowl. Using the applicator or brush provided, collect a small sample from the surface of the stool - you don't need a large amount.
Keep your test kit at room temperature and away from heat, as extreme temperatures can affect accuracy. Collect your sample on a day when you can return it to the laboratory quickly - most kits should be returned within 14 days of collection. Write the collection date on the test card and seal it according to instructions. If you need to collect multiple samples, spread them out over consecutive bowel movements rather than collecting from the same stool.
What Do the Results Mean?
A negative result means no blood was detected in your stool sample, suggesting lower likelihood of colorectal cancer or significant polyps. A positive result means blood was detected and requires follow-up with colonoscopy - however, about 95% of positive results are NOT caused by cancer. Common causes include hemorrhoids, polyps, diverticulosis, and inflammatory bowel conditions.
Understanding your fecal occult blood test results requires recognizing both what the test can and cannot tell you. The test is designed to detect the presence of blood in stool, not to diagnose specific conditions. A result is reported as either positive (blood detected) or negative (no blood detected), and each outcome has important implications for your next steps.
A negative result is reassuring and indicates that no blood was detected in your stool sample at the time of testing. This suggests a lower likelihood of colorectal cancer or significant polyps, but it does not guarantee that you are cancer-free. Some cancers and polyps do not bleed continuously, so it's possible to have a negative test even when abnormalities are present. This is why annual testing is recommended - repeated testing over time increases the chances of detecting any abnormalities that may develop.
A positive result means that blood was detected in your stool sample. While this may cause anxiety, it's important to understand that a positive fecal occult blood test does NOT mean you have cancer. In fact, approximately 95% of people with positive test results do not have colorectal cancer. Many conditions can cause blood in the stool, and most of them are benign and treatable.
Common Causes of Positive Results
When interpreting a positive fecal occult blood test, it's helpful to understand the various conditions that can cause bleeding in the gastrointestinal tract. The most common cause of a positive result is hemorrhoids, which are swollen blood vessels in the rectum that can bleed during bowel movements. Hemorrhoids are extremely common, affecting approximately half of all adults by age 50.
Colorectal polyps are another frequent cause of positive results and are particularly important to identify. While most polyps are benign, certain types (adenomatous polyps) have the potential to develop into cancer over time. Detecting and removing polyps through colonoscopy is one of the primary ways that colorectal cancer screening prevents cancer deaths.
Other conditions that can cause gastrointestinal bleeding include diverticulosis (small pouches in the colon wall), inflammatory bowel disease (Crohn's disease or ulcerative colitis), peptic ulcers, gastritis, angiodysplasia (abnormal blood vessels), and anal fissures. Even swallowing blood from a nosebleed or bleeding gums can occasionally lead to a positive test result.
| Condition | Frequency | Treatment approach |
|---|---|---|
| Hemorrhoids | Very common | Diet changes, topical treatments, procedures if severe |
| Colorectal polyps | Common (30-50% of adults over 50) | Removal during colonoscopy |
| Diverticulosis | Common in older adults | Usually no treatment; diet modifications |
| Colorectal cancer | About 5% of positive tests | Surgery, chemotherapy, radiation as needed |
What Happens If My Test Is Positive?
A positive fecal occult blood test requires follow-up with a colonoscopy to examine the entire colon and identify the source of bleeding. During colonoscopy, your doctor can visualize the colon lining, take biopsies if needed, and remove polyps. Do not repeat the stool test instead of getting a colonoscopy - this delays diagnosis and reduces the screening benefit.
Receiving a positive fecal occult blood test result can be concerning, but it's important to respond appropriately by completing the recommended follow-up. The next step after a positive test is colonoscopy, which allows your healthcare provider to directly visualize the entire colon and rectum, identify any abnormalities, and potentially treat problems during the same procedure.
Colonoscopy is considered the gold standard for examining the colon because it provides a complete view of the large intestine's lining. During the procedure, a gastroenterologist inserts a flexible tube with a camera through the rectum and guides it through the entire colon. If polyps are found, they can usually be removed during the same procedure (polypectomy), and tissue samples (biopsies) can be taken from any suspicious areas.
The timing of follow-up colonoscopy is important. Research shows that delays in completing colonoscopy after a positive stool test are associated with worse outcomes, including higher rates of advanced cancer at diagnosis. Most guidelines recommend completing colonoscopy within 2-3 months of a positive fecal occult blood test, though sooner is generally better.
Some people with positive fecal occult blood test results choose to repeat the stool test rather than proceed with colonoscopy. This approach is strongly discouraged because it delays potential diagnosis, reduces the mortality benefit of screening, and misses opportunities to remove precancerous polyps. Even if a repeat stool test is negative, you should still complete colonoscopy to investigate the original positive result.
What to Expect During Colonoscopy
Understanding what to expect can help reduce anxiety about colonoscopy. The procedure typically takes 30-60 minutes and is performed with sedation, so most patients experience little to no discomfort. Before the procedure, you will need to complete a bowel preparation to clean out the colon - this usually involves drinking a special solution that causes diarrhea to empty the bowel.
On the day of the procedure, you will receive sedation through an IV line, which will make you drowsy and comfortable. Most patients don't remember the procedure afterward. The gastroenterologist will carefully examine the colon lining, noting any abnormalities and removing polyps as needed. Air or carbon dioxide is used to inflate the colon slightly for better visibility.
After the procedure, you will rest in a recovery area until the sedation wears off. You will need someone to drive you home because of the sedation effects. Some bloating and mild cramping are normal and usually resolve within a few hours. Your doctor will discuss the preliminary findings with you and explain when to expect biopsy results if samples were taken.
How Accurate Is the Fecal Occult Blood Test?
The FIT test has a sensitivity of 74-92% for detecting colorectal cancer, meaning it correctly identifies most cancers. Specificity is around 94-97%, meaning few false positives. However, sensitivity for precancerous polyps is lower (20-50%). The test works best when performed annually as part of a regular screening program.
When evaluating any medical test, it's important to understand the concepts of sensitivity and specificity. Sensitivity refers to how well the test identifies people who have the condition - a test with high sensitivity will correctly detect most cases of disease. Specificity refers to how well the test identifies people who don't have the condition - a test with high specificity will have few false positive results.
The fecal immunochemical test (FIT) has excellent performance characteristics for colorectal cancer detection. Studies have shown that FIT detects 74-92% of colorectal cancers (sensitivity) while correctly identifying 94-97% of people without cancer (specificity). This means that FIT is quite reliable for ruling out cancer when negative and that most positive results warrant follow-up.
However, it's important to note that FIT is better at detecting cancer than at detecting precancerous polyps. The sensitivity for advanced adenomas (large precancerous polyps) is considerably lower, ranging from 20-50% depending on the study. This is why annual testing is recommended - repeated testing over time increases the cumulative probability of detecting polyps before they become cancerous.
Factors Affecting Test Accuracy
Several factors can influence the accuracy of fecal occult blood testing. The location of the bleeding source matters - lesions in the lower colon and rectum are more likely to be detected than those in the upper colon because blood has less time to degrade before being collected. The amount and frequency of bleeding also affects detection - cancers and polyps that bleed more heavily or more consistently are more likely to be identified.
Sample handling and timing can impact results. FIT samples should be returned to the laboratory promptly because hemoglobin can degrade over time, especially in warm temperatures. Most laboratories recommend returning samples within 14 days of collection, and sooner is generally better for optimal accuracy.
The cutoff value used to define a positive result also affects test performance. Different laboratories may use different thresholds, and some screening programs use quantitative FIT results that provide a specific hemoglobin concentration rather than just positive or negative. Higher cutoff values increase specificity (fewer false positives) but decrease sensitivity (more missed cancers).
What Are the Alternative Screening Methods?
Alternative colorectal cancer screening methods include colonoscopy (every 10 years), flexible sigmoidoscopy (every 5-10 years), CT colonography (every 5 years), and stool DNA testing (every 1-3 years). Each method has advantages and disadvantages regarding accuracy, invasiveness, cost, and frequency. The best screening test is the one you will actually complete.
While fecal occult blood testing is an effective and convenient screening option, several alternatives are available, each with distinct characteristics. Understanding these options can help you and your healthcare provider choose the most appropriate screening strategy based on your individual circumstances, preferences, and risk factors.
Colonoscopy is considered the most comprehensive screening method because it allows direct visualization of the entire colon and enables simultaneous treatment of polyps. When performed every 10 years with normal results, colonoscopy provides excellent protection against colorectal cancer. However, it requires bowel preparation, sedation, and a day off from normal activities, and carries small risks of bleeding and perforation.
Flexible sigmoidoscopy examines only the lower third of the colon (sigmoid colon and rectum) where approximately half of colorectal cancers develop. It requires less preparation than colonoscopy and usually doesn't require sedation. However, it cannot detect abnormalities in the upper colon, so it's often combined with periodic stool testing.
CT colonography (virtual colonoscopy) uses computed tomography to create detailed images of the colon. It's less invasive than traditional colonoscopy but still requires bowel preparation and involves radiation exposure. If polyps are found, a traditional colonoscopy is needed for removal.
Stool DNA testing (such as Cologuard) combines FIT with testing for genetic mutations associated with colorectal cancer. This test has higher sensitivity than FIT alone but also higher rates of false positives and is more expensive. It's recommended every 1-3 years.
The most important factor in colorectal cancer screening is participation. Research consistently shows that any screening is better than no screening. Talk to your healthcare provider about which option best fits your circumstances, but don't let the perfect be the enemy of the good - the best test is the one you will actually complete on schedule.
Are There Any Risks or Side Effects?
The fecal occult blood test itself has no physical risks or side effects - it simply involves collecting a stool sample at home. The main concerns are psychological distress from positive results and the risks associated with follow-up colonoscopy. False positive results can lead to unnecessary anxiety and colonoscopies, while false negatives may provide false reassurance.
The fecal occult blood test is remarkably safe because it involves no invasion of the body - you simply collect a stool sample at home. There are no physical side effects from the test itself, no radiation exposure, and no need for sedation or medical procedures. This non-invasive nature is one of the test's major advantages and contributes to its acceptance as a screening tool.
However, there are important considerations beyond physical safety. A positive result, even when ultimately found to be due to a benign cause, can cause significant anxiety and emotional distress. Waiting for colonoscopy and then for biopsy results can be stressful. Understanding that most positive results are not caused by cancer can help manage this anxiety, but the emotional impact should not be dismissed.
False positive results lead to additional medical procedures that carry their own risks. Colonoscopy, while generally safe, has rare but potential complications including bleeding (especially after polyp removal), bowel perforation, and reactions to sedation. The risk of serious complications from colonoscopy is approximately 1-3 per 1,000 procedures in screening populations.
Conversely, false negative results can provide false reassurance, potentially delaying diagnosis if symptoms develop. This is why it's important to report any new symptoms (such as blood in stool, changes in bowel habits, unexplained weight loss, or abdominal pain) to your healthcare provider even if your most recent screening test was negative.
How Does Colorectal Cancer Screening Work?
Colorectal cancer screening programs aim to detect cancer early or prevent it by finding and removing precancerous polyps. Screening typically begins at age 45 for average-risk adults and continues through age 75. The choice of screening method (FIT, colonoscopy, etc.) depends on individual preferences, risk factors, and available resources.
Organized colorectal cancer screening programs have been implemented in many countries worldwide, with the goal of reducing cancer incidence and mortality through systematic population-based testing. These programs typically use either fecal occult blood testing or colonoscopy as the primary screening modality, with protocols for follow-up and quality assurance.
In the United States, colorectal cancer screening is recommended for all adults at average risk beginning at age 45. This recommendation was updated from age 50 based on concerning trends showing increasing colorectal cancer rates in younger adults. Screening should continue through age 75, with individualized decisions for ages 76-85 based on overall health and prior screening history.
Multiple professional organizations have issued guidelines for colorectal cancer screening, including the U.S. Preventive Services Task Force (USPSTF), American Cancer Society, American College of Gastroenterology, and World Health Organization. While specific recommendations vary slightly, all agree on the importance of regular screening and offer multiple acceptable screening options.
Making Screening Part of Your Routine
The effectiveness of colorectal cancer screening depends on consistent participation over time. For fecal occult blood testing to provide maximum benefit, it must be performed annually without gaps. Missing years of screening significantly reduces the test's ability to detect early cancers and prevent cancer deaths.
Building screening into your healthcare routine can help ensure consistency. Many people find it helpful to link their annual FIT test to another regular event, such as their birthday or a specific month. Healthcare providers and screening programs often send reminders when tests are due, and some provide test kits directly to patients' homes.
If you prefer colonoscopy, scheduling your next procedure before leaving the endoscopy center can help ensure timely follow-up. Most people with normal colonoscopy results can wait 10 years for their next procedure, while those with polyps may need more frequent surveillance based on the type and number of polyps found.
Frequently asked questions about fecal occult blood testing
Medical References and Sources
This article is based on current medical research and international guidelines. All claims are supported by scientific evidence from peer-reviewed sources.
- U.S. Preventive Services Task Force (2021). "Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement." JAMA. 2021;325(19):1965-1977 Evidence level: Grade A recommendation for adults aged 45-75
- American College of Gastroenterology (2021). "ACG Clinical Guidelines: Colorectal Cancer Screening 2021." Am J Gastroenterol. 2021;116(3):458-479 Comprehensive guidelines for colorectal cancer screening strategies
- Cochrane Database of Systematic Reviews (2022). "Fecal immunochemical test versus guaiac-based fecal occult blood test for colorectal cancer screening." Systematic review comparing FIT and gFOBT test performance. Evidence level: 1A
- World Health Organization (2020). "WHO Position Paper on Colorectal Cancer Screening." International recommendations for population-based screening programs
- Lee JK, et al. (2014). "Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis." Annals of Internal Medicine. 160(3):171-181. Meta-analysis establishing FIT sensitivity and specificity parameters
- Rex DK, et al. (2017). "Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer." Gastroenterology. 153(1):307-323. Joint recommendations from multiple gastroenterology societies
Evidence grading: This article uses the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) for evidence-based medicine. Evidence level 1A represents the highest quality of evidence, based on systematic reviews of randomized controlled trials.
iMedic Editorial Standards
📋 Peer Review Process
All medical content is reviewed by at least two licensed specialist physicians before publication.
🔍 Fact-Checking
All medical claims are verified against peer-reviewed sources and international guidelines.
🔄 Update Frequency
Content is reviewed and updated at least every 12 months or when new research emerges.
✏️ Corrections Policy
Any errors are corrected immediately with transparent changelog. Read more
Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in gastroenterology, preventive medicine, oncology, and laboratory medicine.